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Abstract 
The rapid increase in the number of Coronavirus Disease 2019 (COVID-19) cases, including in Padang, has led 
the government to designate several hospitals as referrals for COVID-19 patients. The profile of COVID-19 patients is 
needed to describe the pattern of this disease in Padang. Objectives: To revealed the profile of COVID-19 patients in 
SPH, Indonesia. Methods: This was a retrospective study. This study was conducted and collected data of COVID-19 
patients from March to June 2020. Results: There are 54 patients with mean age of 50.93 (14.6) years old, 43% male 
and 57% female. The clinical manifestations are cough (74%), fever (37%), sore throat (22%), and fatigue (35%). 
There are 82% of patients admitted that they have contacted with other COVID-19 patients or have activities in 
COVID-19 cluster area, and only 7% have traveled to other cities. The mean length of stay is 31.91 (14.87) days. The 
mean laboratory data: Hemoglobin 13.7 (1.39) gr/dl, WBC 8,037.04 (2,846.27) /mm3, platelet 274,389 (75,053.80) 
/mm3, and NLR 3.16 (3.37). Chest radiograph results are bronchopneumonia (22.22%), cardiomegaly (7.41%), and 
normal (70.37%). Conclusion: The profile of COVID-19 patients in SPH is more in female patients, cough is the most 
clinical manifestation that appeared, the mean laboratory data (hemoglobin, WBC, and platelet) are normal, and 
normal chest radiography is the most chest radiograph results in these patients. 
Kata kunci: COVID-19, Padang, profile  
 
Abstrak 
Peningkatan kasus Coronavirus Disease 2019 (COVID-19) yang cepat, termasuk di Padang, mendorong 
pemerintah mempersiapkan beberapa rumah sakit untuk menjadi rujukan pasien COVID-19. Profil pasien COVID-19 
penting untuk menjelaskan gambaran penyakit ini di Padang. Tujuan: Mendapatkan profil pasien COVID-19 di Semen 
Padang Hospital (SPH). Metode: Penelitian ini merupakan studi retrospektif pada pasien COVID-19 dari Maret hingga 
Juni 2020. Hasil: Terdapat 54 pasien dengan rerata umur 50.93 (14.6) tahun, 43% pria dan 57% wanita. Manifestasi 
klinis adalah batuk (74%), demam (37%), nyeri tenggorokan (22%), dan lelah (35%). Terdapat 82% pasien yang 
kontak dengan pasien COVID-19 lain atau memiliki riwayat aktivitas di daerah klaster COVID-19, dan hanya 7% yang 
memiliki riwayat bepergian ke luar kota. Rerata lama rawatan adalah 31.91 (14.87) hari. Rerata hasil laboratorium: 
Hemoglobin 13.7 (1.39) gr/dl, leukosit 8,037.04 (2,846.27) /mm3, trombosit 274,389 (75,053.80) /mm3, dan NLR 3.16 
(3.37). Hasil pemeriksaan radiologi thoraks adalah bronkopneumonia (22.22%), kardiomegali (7.41%), dan normal 
(70.37%). Simpulan: Profil pasien COVID-19 di SPH adalah lebih banyak wanita, batuk merupakan manifestasi klinis 
yang terbanyak, rerata hasil laboratorium (hemoglobin, leukosit, dan trombosit) normal, dan gambaran radiologi 
thoraks yang terbanyak adalah normal. 
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Coronavirus Disease 2019 (COVID-19) cases 
have started to be reported in Indonesia since March 
2020.1,2 COVID-19 has also spread to almost all 
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Health Organization (WHO) declared COVID-19 a 
pandemic.3 
The rapid increase in the number of cases, 
including in Padang, has led the government to 
designate several hospitals as referrals for COVID-19 
patients. One such hospital is Semen Padang Hospital 
(SPH). This hospital treats mild and moderate COVID-
19 patients. The profile of COVID-19 patients is 
needed to describe the pattern of this disease in 
Padang. The aim of this study was to reveal the profile 
of COVID-19 patients in SPH, Indonesia. 
 
METHODS 
This was a retrospective study conducted in 
SPH, Padang, West Sumatera, Indonesia. This study 
was conducted and collected data of COVID-19 
patients from March 2020 to June 2020. This study 
involved all COVID-19 patients more than 18 years 
old. All blood samples and chest radiographs from this 
study participants were routine-test when patients 
were admitted to the hospital. 
Categorical scale data was written in frequencies 
and percentages, while interval data or ratio scale was 
written in mean (standard deviation). All data is 




There are 54 patients with mean age of 50.93 
(14.6) years old, 43% male and 57% female. The 
clinical manifestations are cough (74%), fever (37%), 
sore throat (22%), and fatigue (35%). There are 82% 
of patients admitted that they have contacted with 
other COVID-19 patients or have activities in COVID-
19 cluster area, and only 7% have traveled to other 
cities. The mean length of stay is 31.91 (14.87) days. 
The mean laboratory data: Hemoglobin 13.7 
(1.39) gr/dl, white blood cells (WBC) 8,037.04 
(2,846.27) /mm3, platelet 274,389 (75,053.80) /mm3, 
and neutrophil to lymphocyte ratio (NLR) 3.16 (3.37). 
Chest radiograph results are bronchopneumonia 
(22,22%), cardiomegaly (7.41%), and normal 
(70.37%). Research’s subjects characteristics can be 
seen in Table 1. 
 
 
Table 1. Baseline characteristics 
Characteristics 
(n=54) 
Mean (SD) n (%) 



















































The mean age of COVID-19 patients in this study 
was 50.93 (14.6) years. Pericas et al (2020) reported 
that the characteristics of COVID-19 patients in China 
were the most in the age group 30-79 years. The 
mean age ranges from 47 - 56 years.4 Dawood et al 
(2020) added that most cases were in the age group 
over 50 years.5 This is supported by Bulut and Kato 
(2020), who reported that the largest age group in 
Spain and Canada is the 50 - 59 year-old group 
(18.8% and 19%).6 Bi et al (2020) found that the 
largest age group was in the 30 - 39 years and 60 - 69 
years age group (22%).7 In Indonesia, according to 
Sutaryono et al (2020) the largest age group is the age 
group 30-49 years (38.91%).8 
In this study, it was found that there were more 
women than men. Bi et al (2020) also found the same 
results (52% vs 48%).7 However, this result is different 
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more men than women.4 A report by Dawood et al 
(2020) which states that there are more men than 
women.5 Sutaryono et al (2020) also reported that 
more men suffer from COVID-19 (58.94%).8 
Bi et al (2020) added that 84% of COVID-19 
patients present with fever symptoms. Most symptoms 
after fever are cough (59.4 - 81.8%) and fatigue (38.1 - 
69.6%). Not all patients admitted to the hospital with 
fever, even some patients with severe COVID-19 do 
not experienced it.7 Pericas et al (2020) found that the 
most symptoms were fever and cough.4 In this study, it 
was found that cough was the most symptom of 
COVID-19 patients. This result is supported by 
Sutaryono et al (2020), who reported coughing was 
the most common symptom.8 Other studies also 
concluded that fever and cough are the most prevalent 
symptoms of COVID-19 worldwide.9,10,11 
The most laboratory results in COVID-19 
patients, according to Ge et al (2020) are an increase 
in C-reactive protein (60.7 - 86.3%) and lymphopenia 
(35.3 - 82.1%).12 Ahnach et al (2020) concluded that 
C-reactive protein (CRP) could be a predictor of 
disease severity during COVID-19 infection.13 Wang 
(2020) found that in the early stage of COVID-19, CRP 
levels were positively correlated with lung lesions.14 
Leukopenia was found in only 9.1 - 33.7% of COVID-
19 patients. However, Wu et al (2020) added that 
leucocytosis could occur when accompanied by 
secondary bacterial infection.15 
In this study, the mean complete peripheral blood 
laboratory results were normal. Leukopenia was found 
in 16.67% of patients, while leucocytosis was found in 
20.37% of patients. Patients with thrombocytopenia 
were found in only 1.85% of patients. The average 
NLR obtained was 3.16. This is likely because most of 
the patients treated were COVID-19 patients with mild 
to moderate symptoms. Pericas et al (2020) added 
that NLR is related to the severity of COVID-19 
symptoms.4 Other studies also concluded that NLR 
has good predictive values on disease severity and 
mortality in patients with COVID-19 infection.16,17,18 
Pericas et al (2020) reported that the 
radiological features of patients with COVID-19 varied 
from normal chest X-rays or CT scans in about 10% of 
cases to pulmonary fibrosis.4 In a study by Ge et al  
(2020), a radiological examination for the diagnosis of 
COVID-19 was a chest computed tomography (CT) 
examination. The CT scan in COVID-19 patients is 
diverse and changing rapidly. A normal picture on a 
radiological examination cannot rule out a diagnosis of 
COVID-19.12,19 
Sutaryono et al (2020) reported that the most 
comorbidities of COVID-19 were hypertension 
(34.85%), diabetes mellitus (25.76%), and heart 
disease (17.05%).8 In this study, hypertension was 
found in 28% of patients, diabetes mellitus in 13% of 
patients, and dyspepsia in 20% of patients. Other 
studies assessed the prevalence of comorbidities 
might be risk factors for severe COVID-19 patients.20,21 
The length of stay (LoS) of COVID-19 patients in 
this study was influenced by the policies used in 
determining which patients to discharge. The 
requirement for discharge patient is a patient who has 
a negative PCR swab twice in a row. However, the 
LoS in this study is longer than the results of the study 
by Octavia et al (2020) in Dr. Saiful Anwar Malang 
Hospital with a mean LoS of 7.8 (2.44) days.22 
 
CONCLUSION 
The profile of COVID-19 patients in SPH is more 
in female patients,  cough is the most clinical 
manifestation that appeared, the mean laboratory data 
(hemoglobin, WBC, and platelet) are normal, and 
normal chest radiography is the most chest radiograph 
results in these patients. 
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